DeepMind, Google's London-based artificial intelligence company, has started training neural networks to recognize the signs of eye disease in medical images. A partnership with Moorfields Eye Hospital in London has given the company access to about a million anonymized retinal scans, which DeepMind will feed into its artificial intelligence software. The project will target two of the most common eye diseases--age-related macular degeneration and diabetic retinopathy. More than 100 million people around the world have these conditions.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados